Design and characterisation of long-R3-insulin-like growth factor-I muteins which show resistance to pepsin digestion (Q30425812)

21 June 2017

title

Design and characterisation of long-R3-insulin-like growth factor-I muteins which show resistance to pepsin digestion (English)

1 reference

21 June 2017

Bryant KJ

1 reference

21 June 2017

Read LC

series ordinal

1 reference

21 June 2017

Forsberg G

series ordinal

1 reference

21 June 2017

Wallace JC

series ordinal

1 reference

21 June 2017

publication date

1 January 1996

1 reference

21 June 2017

published in

Growth Factors Journal

1 reference

21 June 2017

1 reference

21 June 2017

issue

3-4

1 reference

21 June 2017

page(s)

261-272

1 reference

Suggestions for "safe" residue substitutions in site-directed mutagenesis.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08977199609003227

Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977199609003227

Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977199609003227

Novel oral drug formulations. Their potential in modulating adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977199609003227

Purification and partial sequence analysis of insulin-like growth factor-1 from bovine colostrum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977199609003227

Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977199609003227

Production and characterization of recombinant insulin-like growth factor-I (IGF-I) and potent analogues of IGF-I, with Gly or Arg substituted for Glu 3, following their expression in Escherichia coli as fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977199609003227

Expression of a biologically active analogue of somatomedin-C/insulin-like growth factor I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977199609003227

Drug delivery systems 5A. Oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977199609003227

Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977199609003227

Three-dimensional structure of human insulin-like growth factor-I (IGF-I) determined by 1H-NMR and distance geometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977199609003227

10.3109/08977199609003227

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference